Amphastar Pharmaceuticals, Inc. (AMPH) vs Xeris Biopharma Holdings, Inc. (XERS)

Amphastar Pharmaceuticals, Inc. and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $1.6B against $1.1B — 1.5× the size. Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Amphastar Pharmaceuticals, Inc. trades at 15.0×. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 36.3% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs −5.12%) and the lower return on invested capital (6.57% vs 18.9%). Across the 20 metrics below, Amphastar Pharmaceuticals, Inc. leads on 13 and Xeris Biopharma Holdings, Inc. on 7.